Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
AstraZeneca
Baxter
Johnson and Johnson

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for MedPointe Healthcare Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2007)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

MedPointe Healthcare Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-06-22
Court District Court, D. Delaware Date Terminated 2008-10-28
Cause 28:1338 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties MEDA PHARMACEUTICALS INC.; SUN PHARMACEUTICAL INDUSTRIES LTD.
Patents 5,164,194
Attorneys Anne S. Toker; David B. Abramowitz; Francis J. Murphy , Jr.; Jameson A.L. Tweedie; John M. Desmarais; Keith D. Parr; Kelly E. Farnan; Kevin M. Nelson; Peter J. Armenio; Scott B. Feder
Firms Murphy, Spadaro & Landon
Link to Docket External link to docket
Small Molecule Drugs cited in MedPointe Healthcare Inc. v. Sun Pharmaceutical Industries Ltd.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for MedPointe Healthcare Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-06-22 1 Complaint infringement of United Statos Patent No. 5,164,194 ("the '194 patent"). 'l'his action… United States Patent nn I~Iettche USOG§\()¢$§‘)~§A ft 13 Patent Number: 5,164,194 Nov. 17, 1992 […;ENT NO. : 5,164,194 ISSUED : November 17, 1992 IN`V'ENTOR(S) : Helmut Hettcbe PATENT OWNBR : Asta…-cv-00407-SLR Document 1-2 Filed 06/22/2007 5,164,194 7 ized lactose nrc then incorporated in portions…and (d) and l400(b)r THE PATENT 7. On Novernber 17, 1992, the ‘194 patent, titled "Azelastine Containing External link to document
2007-09-14 12 Answer to Counterclaim and enforceability of UrS, Patent Nor 5,164,194 ("tiie '194 patent") REPLY TO COUNTERCLAIM…any claim of the '194 patent; B, Declaring that U~Sm Patent No. 5,164,194 is invalid for failure to… Declaring that U.Si Patent Noi 5,164,194 is unenforceable due to the ‘194 patent applicants inequitable…application issued on Noveinher 17, 1992 as U.S. Patent Not 5,164,194. MedPointe further admits that the Januaty…belief`, the ‘194 patent is unenforceable due to inequitable conduct committed by the patent applicants during External link to document
2008-05-16 30 Stipulation remains the current owner of U.S. Patent No. 5,164,194, the patent at issue in this action; …2007 28 October 2008 1:07-cv-00407 830 Patent None District Court, D. Delaware External link to document
2008-07-17 38 Notice (Other) herein, the term “‘194 patent” shall mean United States Patent No. 5,164,194. 5. As used…prosecution of the indicated patents or patent applications in the United States Patent and Trademark Office …16. The term “prior art” to a patent means all publications, patents, and all uses, sales, offers for… the ‘194 patent. 14. All evidence establishing inventorship of the ‘194 patent by Helmut … ‘194 patent. 23. Meda’s contentions regarding Sun’s infringement of the ‘194 patent. External link to document
2007-06-25 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,164,194; (ead) (Entered: 06…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 5,164,194 … Industries Ltd. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2007-08-27 7 Answer to Complaint Invaliditv of U.S. Patent No. 5,164,194) Upon information and belief, the claims of the ‘194 patent are invalid…The application later issued as U.S. Patent No. 5,164,194, the patent in dispute l4. Upon information and…eclaring that U.S. Patent No. 5,164,194 is unenforceable due to the "194 patent applicants’ inequitable…AFFIRMATIVE I)E FENSE (Noninfrirlgement of U.S. Patent No. 5,164,194) T`he manufacture use, sale, offer to sell…by the patent applicants during prosecution of the ‘194 patent before the United States Patent and Tradeinarl External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Boehringer Ingelheim
McKesson
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.